You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2024

Details for Patent: 6,514,980


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,514,980
Title: Nucleoside analogs in combination therapy of herpes simplex infections
Abstract:A pharmaceutical product comprising a nucleoside analogue active against herpes simplex virus, such as acyclovir/valaciclovir or penciclorivir/famciclovir, and an immunosuppressant, as a combined preparation for simultaneous, separate or sequential use in the treatment and/or prevention of herpes simplex virus infections.
Inventor(s): Boyd; Malcolm Richard (Epsom, GB)
Assignee: Novartis International Pharmaceutical Ltd. (Hamilton, BM)
Application Number:09/626,015
Patent Claim Types:
see list of patent claims
Composition; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 6,514,980

Introduction

When analyzing a patent, particularly one like United States Patent 6,514,980, it is crucial to delve into the specifics of its scope and claims. This analysis will help in understanding the protective boundaries of the patent, its relevance in the market, and potential gaps or opportunities.

What is a Patent?

Before diving into the specifics of US Patent 6,514,980, it's essential to understand the basics of a patent. A patent is a grant of exclusive rights to an inventor for their invention, typically for a period of 20 years from the filing date. It includes a complete description of the invention, followed by "claims" that define the inventive technology owned by the patent holder[2].

Anatomy of a Patent

A patent consists of several key components:

  • Specification: This includes an abstract, detailed description, and figures that describe the invention.
  • Claims: These define the scope of the invention and are the most critical part of the patent application. Claims can be independent or dependent and must be supported by the specification and drawings[2][5].

Understanding Patent Claims

Patent claims are the heart of a patent application, as they define the exclusive rights granted by the USPTO. Here are some key points about claims:

  • Definition: Claims particularly point out and distinctly claim the subject matter regarded as the invention[5].
  • Types: Independent claims stand alone, while dependent claims refer back to an independent claim and further limit it[5].
  • Drafting: Drafting patent claims is an art that requires precision and strategy to ensure broad yet defensible claims[5].

Analyzing US Patent 6,514,980

Patent Details

To analyze US Patent 6,514,980, one would typically start by reviewing the patent document itself. Here are some steps to follow:

  • Title and Abstract: The title and abstract provide a brief overview of the invention.
  • Detailed Description: This section explains the invention in detail, including any background information, summary of the invention, and detailed description of the preferred embodiments.
  • Claims: The claims section is where the patentee defines the scope of their invention. Each claim must be supported by the specification and drawings.

Scope of the Invention

The scope of the invention is defined by the claims. Here’s how to interpret them:

  • Independent Claims: Identify the independent claims as they set the broad boundaries of the invention.
  • Dependent Claims: Dependent claims further narrow down the invention, often specifying particular aspects or embodiments.
  • Claim Language: The language used in the claims is critical. It must be clear and distinct to avoid ambiguity and potential infringement issues[5].

Claim Coverage Matrix

To understand the coverage of the patent, a Claim Coverage Matrix can be useful. This matrix categorizes patents by claims and scope concepts, helping to identify which patents and claims actively protect the intellectual property and where gaps or opportunities exist[3].

Patent Landscape Analysis

Competitor Patents

Analyzing the patent landscape involves looking at similar patents held by competitors. This can be done using tools like the USPTO's Global Dossier or Patent Examination Data System (PEDS)[4].

  • Global Dossier: This service provides access to the file histories of related applications from participating IP Offices, helping to identify patent families and related applications.
  • PEDS: This system allows users to search, view, and download bibliographic data for publicly available patent applications.

Citation Data

Reviewing citation data, such as through the Common Citation Document (CCD) application, can help in understanding the prior art cited by various patent offices. This consolidates citation data, enabling a comprehensive view of the invention's novelty and non-obviousness[4].

Practical Strategies for Managing Patent Rights

Post-Grant Review

After a patent is granted, it can still be challenged through various post-grant review processes such as Inter Partes Review (IPR), Post-Grant Review (PGR), and Ex Parte Reexamination. These processes can be used to challenge the validity of the patent claims[2].

  • IPR: This is a faster and more cost-effective way to challenge patent validity compared to federal district court litigation. It is particularly useful if a company is sued for patent infringement or if a patent prevents the company from freely operating[2].

Claim Charts

Using claim charts generated by tools like ClaimScape® can help in reviewing patent coverage. These charts categorize claims by scope concepts, making it easier to determine if there are gaps in the current coverage and to identify future design opportunities[3].

Key Takeaways

  • Patent Claims: The claims section of a patent is crucial as it defines the exclusive rights granted by the USPTO.
  • Scope Analysis: Understanding the scope of the invention involves analyzing both independent and dependent claims.
  • Patent Landscape: Analyzing the patent landscape includes reviewing competitor patents and citation data to understand the broader intellectual property environment.
  • Post-Grant Review: Various post-grant review processes can be used to challenge the validity of patent claims.
  • Claim Coverage Matrix: Tools like Claim Coverage Matrix and claim charts help in identifying gaps and opportunities in patent coverage.

FAQs

  1. What is the purpose of patent claims in a patent application?

    • Patent claims define the exclusive rights granted by the USPTO and are the most important part of the patent application as they specify what is protected by the patent[5].
  2. How do independent and dependent claims differ?

    • Independent claims stand alone and define the broad boundaries of the invention, while dependent claims refer back to an independent claim and further limit it[5].
  3. What is the significance of the Global Dossier in patent analysis?

    • The Global Dossier provides access to the file histories of related applications from participating IP Offices, helping to identify patent families and related applications[4].
  4. Why is post-grant review important for managing patent rights?

    • Post-grant review processes like IPR and PGR allow for challenging the validity of patent claims in a faster and more cost-effective manner than federal district court litigation[2].
  5. How can claim charts help in managing patent rights?

    • Claim charts categorize claims by scope concepts, making it easier to determine if there are gaps in the current coverage and to identify future design opportunities[3].

Sources

  1. GAO Report: Assessing Factors That Affect Patent Infringement Litigation[1].
  2. Dorsey & Whitney: Practical Strategies for Managing Patent Rights[2].
  3. Schwegman, Lundberg & Woessner: Patent Analytics[3].
  4. USPTO: Search for Patents[4].
  5. IPWatchdog: An Introduction to Patent Claims[5].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,514,980

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,514,980

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9601544Jan 26, 1996

International Family Members for US Patent 6,514,980

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 005551 ⤷  Subscribe
Austria 238796 ⤷  Subscribe
Australia 1550697 ⤷  Subscribe
Australia 713202 ⤷  Subscribe
Brazil 9707304 ⤷  Subscribe
Canada 2244268 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.